Is Acasti Pharma Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ACST) stock is to Strong Buy ACST stock.
Out of 2 analysts, 1 (50%) are recommending ACST as a Strong Buy, 1 (50%) are recommending ACST as a Buy, 0 (0%) are recommending ACST as a Hold, 0 (0%) are recommending ACST as a Sell, and 0 (0%) are recommending ACST as a Strong Sell.
What is ACST's forecast return on equity (ROE) for 2024-2026?
(NASDAQ: ACST) forecast ROE is 8.76%, which is considered weak.
What is ACST's Price Target?
According to 2 Wall Street analysts that have issued a 1 year ACST price target, the average ACST price target is $2.45, with the highest ACST stock price forecast at $2.50 and the lowest ACST stock price forecast at $2.40.
On average, Wall Street analysts predict that Acasti Pharma's share price could reach $2.45 by Feb 15, 2024. The average Acasti Pharma stock price prediction forecasts a potential upside of 349.54% from the current ACST share price of $0.55.
What is ACST's forecast return on assets (ROA) for 2024-2026?
(NASDAQ: ACST) forecast ROA is 7.26%, which is higher than the forecast US Biotechnology industry average of 0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.